NAPABUCASIN: 78 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
78
Total FAERS Reports
9 (11.5%)
Deaths Reported
59
Hospitalizations
78
As Primary/Secondary Suspect
8
Life-Threatening
1
Disabilities
First Report: 20170115 · Latest Report: 20231203
What Are the Most Common NAPABUCASIN Side Effects?
#1 Most Reported
Neutropenia
9 reports (11.5%)
#2 Most Reported
Abdominal pain
9 reports (11.5%)
#3 Most Reported
Diarrhoea
7 reports (9.0%)
All NAPABUCASIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Abdominal pain | 9 | 11.5% | 2 | 8 |
| Neutropenia | 9 | 11.5% | 1 | 4 |
| Diarrhoea | 7 | 9.0% | 1 | 5 |
| Anaemia | 6 | 7.7% | 0 | 6 |
| Cystoid macular oedema | 5 | 6.4% | 0 | 0 |
| Hypokalaemia | 5 | 6.4% | 1 | 4 |
| Nausea | 5 | 6.4% | 1 | 3 |
| Neuropathy peripheral | 5 | 6.4% | 1 | 0 |
| Pneumonia | 5 | 6.4% | 1 | 5 |
Who Reports NAPABUCASIN Side Effects? Age & Gender Data
Gender: 34.1% female, 65.9% male. Average age: 63.3 years. Most reports from: US. View detailed demographics →
Is NAPABUCASIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 5 | 1 | 5 |
| 2018 | 24 | 2 | 24 |
| 2019 | 23 | 1 | 21 |
| 2020 | 6 | 1 | 6 |
| 2023 | 2 | 0 | 2 |
What Is NAPABUCASIN Used For?
| Indication | Reports |
|---|---|
| Colorectal cancer metastatic | 34 |
| Pancreatic carcinoma metastatic | 20 |
| Colorectal cancer | 7 |
| Adenocarcinoma pancreas | 5 |
Official FDA Label for NAPABUCASIN
Official prescribing information from the FDA-approved drug label.